Diagnosis and prevention of chronic kidney allograft loss

The Lancet

Volumn 378, Issue 9800, 2011, Pages 1428-1437

  Nankivell, Brian J ^a   Kuypers, Dirk Rj ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA 2 MICROGLOBULIN; CALCIUM CHANNEL BLOCKING AGENT; CD30 ANTIGEN; CIPROFLOXACIN; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOPTERIN; TACROLIMUS;

ACNE; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BK VIRUS; BLOOD GROUP ABO SYSTEM; BLOOD PRESSURE; CELL EXPANSION; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENCY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; ECHOGRAPHY; ENZYME LINKED IMMUNOSPOT ASSAY; GINGIVA HYPERPLASIA; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HEADACHE; HEMATURIA; HIRSUTISM; HLA MATCHING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MONONUCLEAR CELL; NEPHROTOXICITY; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SWOLLEN FACE; SYSTEMATIC REVIEW (TOPIC); T LYMPHOCYTE ACTIVATION; TREMOR; URINALYSIS;

EID: 80054712257     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60699-5     Document Type: Review

References (92)

1. S McDonald, G Russ, S Campbell, S Chadban Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome Am J Transplant 7 2007 1201 1208 (Pubitemid 46646787)
2. HU Meier-Kriesche, JD Schold, B Kaplan Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4 2004 1289 1295 (Pubitemid 39013575)
3. M Zeier, B Dohler, G Opelz, E Ritz The effect of donor gender on graft survival J Am Soc Nephrol 13 2002 2570 2576
4. D Hernandez, A Sanchez-Fructuoso, JM Gonzalez-Posada et al. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year Transplantation 88 2009 803 809
5. MB Prendergast, RS Gaston Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation Clin J Am Soc Nephrol 5 2010 1305 1311
6. D Hernandez, A Sanchez-Fructuoso, JM Gonzalez-Posada et al. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year Transplantation 88 2009 803 809
7. BJ Nankivell, JR Chapman Chronic allograft nephropathy: current concepts and future directions Transplantation 81 2006 643 654
8. BJ Nankivell, RJ Borrows, CL Fung, PJ O'Connell, RD Allen, JR Chapman The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326 2333 (Pubitemid 37509740)
9. CA White, A Akbari, S Doucette, D Fergusson, GA Knoll Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? Clin Chem 56 2010 474 477
10. CA White, D Huang, A Akbari, J Garland, GA Knoll Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review Am J Kidney Dis 51 2008 1005 1015 (Pubitemid 351697570)
11. BL Kasiske, MA Andany, B Danielson A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure Am J Kidney Dis 39 2002 762 768 (Pubitemid 34263350)
12. B Kaplan, J Schold, HU Meier-Kriesche Poor predictive value of serum creatinine for renal allograft loss Am J Transplant 3 2003 1560 1565 (Pubitemid 37541513)
13. X He, J Moore, S Shabir et al. Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients Transplantation 87 2009 384 392
14. A Cherukuri, MP Welberry-Smith, JE Tattersall et al. The clinical significance of early proteinuria after renal transplantation Transplantation 89 2010 200 207
15. J Radermacher, M Mengel, S Ellis et al. The renal arterial resistance index and renal allograft survival N Engl J Med 349 2003 115 124 (Pubitemid 36818781)
16. AP de Vries, WJ van Son, JJ van der Heide et al. The predictive value of renal vascular resistance for late renal allograft loss Am J Transplant 6 2006 364 370 (Pubitemid 43382173)
17. O Bestard, P Nickel, JM Cruzado et al. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients J Am Soc Nephrol 19 2008 1419 1429
18. RJ Kowalski, DR Post, RB Mannon et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay Transplantation 82 2006 663 668 (Pubitemid 44395237)
19. M Hu, D Watson, GY Zhang et al. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells J Immunol 180 2008 6593 6603
20. B Li, C Hartono, R Ding et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine N Engl J Med 344 2001 947 954 (Pubitemid 32240312)
21. T Muthukumar, D Dadhania, R Ding et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients N Engl J Med 353 2005 2342 2351 (Pubitemid 41713746)
22. R Weimer, C Susal, S Yildiz et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens Am J Transplant 6 2006 1865 1874 (Pubitemid 44024958)
23. SO Grebe, TF Mueller Immune monitoring in organ transplantation using neopterin Curr Drug Metab 3 2002 189 202 (Pubitemid 34326530)
24. A Arjona Soluble CD30 for the prediction and detection of kidney transplant rejection Drug News Perspect 22 2009 409 413
25. D Anglicheau, M Suthanthiran Noninvasive prediction of organ graft rejection and outcome using gene expression patterns Transplantation 86 2008 192 199
26. XB Ling, TK Sigdel, K Lau et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection J Am Soc Nephrol 21 2010 646 653
27. TK Sigdel, A Kaushal, M Gritsenko et al. Shotgun proteomics identifies proteins specific for acute renal transplant rejection Proteomics Clin Appl 4 2010 32 47
28. B Schroppel, B Kruger, L Walsh et al. Tubular expression of KIM-1 does not predict delayed function after transplantation J Am Soc Nephrol 21 2010 536 542
29. IE Hall, SG Yarlagadda, SG Coca et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation J Am Soc Nephrol 21 2010 189 197
30. C Moers, JM Smits, MH Maathuis et al. Machine perfusion or cold storage in deceased-donor kidney transplantation N Engl J Med 360 2009 7 19
31. M Gasser, AM Waaga, IA Laskowski, NL Tilney The influence of donor brain death on short and long-term outcome of solid organ allografts Ann Transplant 5 2000 61 67
32. ZM El-Zoghby, MD Stegall, DJ Lager et al. Identifying specific causes of kidney allograft loss Am J Transplant 9 2009 527 535
33. PS Rao, A Ojo The alphabet soup of kidney transplantation: SCD, DCD, ECD - fundamentals for the practicing nephrologist Clin J Am Soc Nephrol 4 2009 1827 1831
34. J Pascual, J Zamora, JD Pirsch A systematic review of kidney transplantation from expanded criteria donors Am J Kidney Dis 52 2008 553 586
35. M Giessing, TF Fuller, F Friedersdorff et al. Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients J Am Soc Nephrol 20 2009 37 40
36. KE King, DS Warren, M Samaniego-Picota, S Campbell-Lee, RA Montgomery, WM Baldwin 3rd Antibody, complement and accommodation in ABO-incompatible transplants Curr Opin Immunol 16 2004 545 549 (Pubitemid 39165879)
37. JI Roodnat, JA Kal-van Gestel, W Zuidema et al. Successful expansion of the living donor pool by alternative living donation programs Am J Transplant 9 2009 2150 2156
38. PF Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715 2729 (Pubitemid 39665325)
39. AC Webster, LP Ruster, R McGee et al. Interleukin 2 receptor antagonists for kidney transplant recipients Cochrane Database Syst Rev 1 2010 CD003897
40. H Ekberg, H Tedesco-Silva, A Demirbas et al. Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2007 2562 2575 (Pubitemid 350294223)
41. BJ Nankivell, JR Chapman The significance of subclinical rejection and the value of protocol biopsies Am J Transplant 6 2006 2006 2012 (Pubitemid 44199535)
42. AC Webster, RC Woodroffe, RS Taylor, JR Chapman, JC Craig Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data BMJ 331 2005 810
43. JA Butler, P Roderick, M Mullee, JC Mason, RC Peveler Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review Transplantation 77 2004 769 776 (Pubitemid 38366989)
44. PE Morrissey, ML Flynn, S Lin Medication noncompliance and its implications in transplant recipients Drugs 67 2007 1463 1481 (Pubitemid 47026394)
45. S Bunnapradist, PM Ambuhl Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies Clin Transplant 22 2008 815 821
46. J Pascual, J Zamora, C Galeano, A Royuela, C Quereda Steroid avoidance or withdrawal for kidney transplant recipients Cochrane Database Syst Rev 1 2009 CD005632
47. SR Knight, PJ Morris Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis Transplantation 89 2010 1 14
48. BL Kasiske, MG Zeier, JR Chapman et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary Kidney Int 77 2010 299 311
49. RN Fine, Y Becker, S De Geest et al. Nonadherence consensus conference summary report Am J Transplant 9 2009 35 41
50. F Tedla, R Hayashi, SI McFarlane, MO Salifu Hypertension after renal transplant J Clin Hypertens (Greenwich) 9 2007 538 545
51. NB Cross, AC Webster, P Masson, PJ O'Connell, JC Craig Antihypertensive treatment for kidney transplant recipients: systematic review and meta-analysis of randomised controlled trials Transplantation 88 2009 7 18
52. G Heinze, C Mitterbauer, H Regele et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation J Am Soc Nephrol 17 2006 889 899
53. SD Navaneethan, V Perkovic, DW Johnson, SU Nigwekar, JC Craig, GF Strippoli HMG CoA reductase inhibitors (statins) for kidney transplant recipients Cochrane Database Syst Rev 2 2009 CD005019
54. D Seron, F Oppenheimer, LM Pallardo et al. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial Transplantation 86 2008 82 87
55. Y Akioka, H Chikamoto, S Horita et al. Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy Clin Transplant 23 suppl 20 2009 2 5
56. BJ Nankivell, DA Cohn, ST Spicer, SG Evans, JR Chapman, SM Gruenewald Diagnosis of kidney transplant obstruction using Mag3 diuretic renography Clin Transplant 15 2001 11 18 (Pubitemid 32094329)
57. PJ Dupont, E Psimenou, R Lord, JR Buscombe, AJ Hilson, P Sweny Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux Transplantation 84 2007 351 355 (Pubitemid 47258323)
58. A Schwarz, W Gwinner, M Hiss, J Radermacher, M Mengel, H Haller Safety and adequacy of renal transplant protocol biopsies Am J Transplant 5 2005 1992 1996 (Pubitemid 41039876)
59. G Einecke, J Reeve, B Sis et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies J Clin Invest 120 2010 1862 1872
60. M Mengel The kidney transplant: new horizons Curr Opin Nephrol Hypertens 19 2010 260 265
61. B Sis, GS Jhangri, S Bunnag, K Allanach, B Kaplan, PF Halloran Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
62. K Solez, RB Colvin, LC Racusen et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') Am J Transplant 7 2007 518 526 (Pubitemid 46376465)
63. SR Knight, NK Russell, L Barcena, PJ Morris Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review Transplantation 87 2009 785 794
64. PC Lee, L Zhu, PI Terasaki, MJ Everly HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss Transplantation 88 2009 568 574
65. B Sis, PM Campbell, T Mueller et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause Am J Transplant 7 2007 1743 1752 (Pubitemid 46905427)
66. B Sis, M Mengel, M Haas et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups Am J Transplant 10 2010 464 471
67. RB Colvin Antibody-mediated renal allograft rejection: diagnosis and pathogenesis J Am Soc Nephrol 18 2007 1046 1056 (Pubitemid 46536891)
68. MD Stegall, JM Gloor Deciphering antibody-mediated rejection: new insights into mechanisms and treatment Curr Opin Organ Transplant 15 2010 8 10
69. S Gourishankar, R Leduc, J Connett et al. Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study Am J Transplant 10 2010 324 330
70. FG Cosio, JP Grande, H Wadei, TS Larson, MD Griffin, MD Stegall Predicting subsequent decline in kidney allograft function from early surveillance biopsies Am J Transplant 5 2005 2464 2472
71. M Mengel, J Reeve, S Bunnag et al. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts Am J Transplant 9 2009 1859 1867
72. A Mota, M Arias, EI Taskinen et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years Am J Transplant 4 2004 953 961 (Pubitemid 38745595)
73. FP Schena, MD Pascoe, J Alberu et al. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial Transplantation 87 2009 233 242
74. C Dudley, E Pohanka, H Riad et al. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study Transplantation 79 2005 466 475 (Pubitemid 40280180)
75. J Moore, L Middleton, P Cockwell et al. Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis Transplantation 87 2009 591 605
76. SM Flechner, J Kobashigawa, G Klintmalm Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant 22 2008 1 15 (Pubitemid 351149996)
77. M Naesens, DR Kuypers, M Sarwal Calcineurin inhibitor nephrotoxicity Clin J Am Soc Nephrol 4 2009 481 508
78. BJ Nankivell, RJ Borrows, CL Fung, PJ O'Connell, JR Chapman, RD Allen Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology Transplantation 78 2004 557 565 (Pubitemid 39097102)
79. D Abramowicz, M Del Carmen Rial, S Vitko et al. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study J Am Soc Nephrol 16 2005 2234 2240 (Pubitemid 41716457)
80. AO Ojo, PJ Held, FK Port et al. Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940 (Pubitemid 37064766)
81. FS Shihab, TH Waid, DJ Conti et al. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study Transplantation 85 2008 1261 1269 (Pubitemid 351670474)
82. M Hazzan, M Labalette, MC Copin et al. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial J Am Soc Nephrol 16 2005 2509 2516 (Pubitemid 41725071)
83. O Johnston, D Jaswal, JS Gill, S Doucette, DA Fergusson, GA Knoll Treatment of polyomavirus infection in kidney transplant recipients: a systematic review Transplantation 89 2010 1057 1070
84. EM Briganti, GR Russ, JJ McNeil, RC Atkins, SJ Chadban Risk of renal allograft loss from recurrent glomerulonephritis N Engl J Med 347 2002 103 109 (Pubitemid 34753480)
85. B Ivanyi A primer on recurrent and de novo glomerulonephritis in renal allografts Nat Clin Pract Nephrol 4 2008 446 457
86. G Moroni, B Gallelli, S Quaglini, G Banfi, G Montagnino, P Messa Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis Transpl Int 23 2010 208 216
87. G Canaud, J Zuber, R Sberro et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study Am J Transplant 9 2009 1081 1086
88. HM Kauffman, MA McBride, CS Cors, AM Roza, JJ Wynn Early mortality rates in older kidney recipients with comorbid risk factors Transplantation 83 2007 404 410 (Pubitemid 46667843)
89. PS Rao, DE Schaubel, MK Guidinger et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index Transplantation 88 2009 231 236
90. PS Rao, DE Schaubel, X Jia, S Li, FK Port, R Saran Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients Am J Kidney Dis 49 2007 294 300 (Pubitemid 46178401)
91. D Ansell, UP Udayaraj, R Steenkamp, CR Dudley Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: data from the UK renal registry Am J Transplant 7 2007 1167 1176 (Pubitemid 46643098)
92. R Marcen, D del Castillo, L Capdevila et al. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain Transplantation 87 2009 1340 1346